Patient & Visitor Alert: Because flu cases are on the rise, starting February 24, children 12 and younger
will be restricted from visiting hospitals and certain inpatient facilities throughout Carolinas HealthCare System. Learn more.


Carolinas HealthCare System

Research and Clinical Trials

Title  
A Phase I - II Study of the Safety and Efficacy of a True Human Antibody
Brief Description  
Staphylococcal bacteremia is a serious infection that despite intravenous antibiotic therapy still has a mortality of 20 to 40%. Previous attemopts to augment antibiotic therapy with passive immunization strategies have been met with limited success, due to the presence of the virulence factor, Staphylococcal Protein A (SpA). SpA binds the Fc region of immunoglobulins, effectively neutralizing them, which interferes with complement activation and phagocytosis.
Who may be Eligible  
Patients =18 years of age who have Bacteremia Due to Staphylococcus Aureus
Start Date  
05/01/2014
IRB Number  
05-15-01B
Principal Investigator  
Huynh, Toan
Contact Name  
Julia

For More Information, Contact   Julia  Raddatz , MS
Phone:  (074) 355-8287  Fax:  (704) 355-7730 
Email:  julia.raddatz@carolinashealthcare.org
Address:  Carolinas HealthCare System
1000 Blythe Blvd, MEB 202
Charlotte, NC 28203
Close